APO Research
Talk to an analyst

APO RESEARCH · REPORT

Coronary Pathway Assistive Devices

Compare research editions
View pricing & licenses

Selected research

Industry Research

Coronary Pathway Assistive Devices Industry Research Report 2026

24 December 2025138 pages

Choose your research edition.

Industry ResearchCoronary Pathway Assistive Devices Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Coronary Pathway Assistive Devices Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Coronary Pathway Assistive Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coronary Pathway Assistive Devices Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Coronary Pathway Assistive Devices Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Coronary Pathway Assistive Devices market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Coronary Pathway Assistive Devices market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Coronary Pathway Assistive Devices market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Coronary Pathway Assistive Devices market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Coronary Pathway Assistive Devices include Zhejiang Barty Medical Technology, OrbusNeich Medical Company, MicroPort Scientific Corporation, Suzhou Innomed Medical Device, Shunmei Medical, Shenzhen MicroApproach Medical Technology, Shanghai INT Medical Instruments, Xiamen New Concept Medical Technology and Lepu Medical Technology, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Coronary Pathway Assistive Devices market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Coronary Pathway Assistive Devices.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Coronary Pathway Assistive Devices Market by Company

Zhejiang Barty Medical Technology

OrbusNeich Medical Company

MicroPort Scientific Corporation

Suzhou Innomed Medical Device

Shunmei Medical

Shenzhen MicroApproach Medical Technology

Shanghai INT Medical Instruments

Xiamen New Concept Medical Technology

Lepu Medical Technology

Jiangxi Hongda Medical Equipment Group

Jiangsu ChangMei Medtech

APT Medical

Changzhou JIUHONG Medical Instrument

BrosMed Medical

Beijing Demax Medical Technology

Terumo Corporation

Merit Medical

Medtronic

Curatia Medical

Cordis

Boston Scientific

ASAHI INTECC

Abbott

Coronary Pathway Assistive Devices Segment by Type

Angiographic Assistive Devices

Therapeutic Assistive Devices

Coronary Pathway Assistive Devices Segment by Application

Hospital

Clinic

Others

Coronary Pathway Assistive Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coronary Pathway Assistive Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coronary Pathway Assistive Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coronary Pathway Assistive Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Coronary Pathway Assistive Devices companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Coronary Pathway Assistive Devices Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Coronary Pathway Assistive Devices Revenue Market Share by Type (2021-2026) Table 7. Global Coronary Pathway Assistive Devices Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Coronary Pathway Assistive Devices Revenue Market Share by Type (2027-2032) Table 9. Global Coronary Pathway Assistive Devices Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Coronary Pathway Assistive Devices Revenue Market Share by Application (2021-2026) Table 11. Global Coronary Pathway Assistive Devices Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Coronary Pathway Assistive Devices Revenue Market Share by Application (2027-2032) Table 13. Global Coronary Pathway Assistive Devices Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Coronary Pathway Assistive Devices Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Coronary Pathway Assistive Devices Market Share by Region (2021-2026) Table 16. Global Coronary Pathway Assistive Devices Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Coronary Pathway Assistive Devices Market Share by Region (2027-2032) Table 18. Coronary Pathway Assistive Devices Industry Trends Table 19. Coronary Pathway Assistive Devices Industry Drivers Table 20. Coronary Pathway Assistive Devices Industry Opportunities and Challenges Table 21. Coronary Pathway Assistive Devices Market Restraints Table 22. Global Top Coronary Pathway Assistive Devices Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Coronary Pathway Assistive Devices Revenue Market Share by Players (2021-2026) Table 24. Global Coronary Pathway Assistive Devices Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Coronary Pathway Assistive Devices, Headquarters and Area Served Table 26. Global Coronary Pathway Assistive Devices Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Coronary Pathway Assistive Devices by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Coronary Pathway Assistive Devices Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Coronary Pathway Assistive Devices Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Coronary Pathway Assistive Devices Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Coronary Pathway Assistive Devices Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Coronary Pathway Assistive Devices Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Coronary Pathway Assistive Devices Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Coronary Pathway Assistive Devices Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Coronary Pathway Assistive Devices Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Coronary Pathway Assistive Devices Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Coronary Pathway Assistive Devices Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Coronary Pathway Assistive Devices Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Coronary Pathway Assistive Devices Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Coronary Pathway Assistive Devices Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Coronary Pathway Assistive Devices Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Coronary Pathway Assistive Devices Market Size by Country (2027-2032) & (US$ Million) Table 45. Zhejiang Barty Medical Technology Company Information Table 46. Zhejiang Barty Medical Technology Business Overview Table 47. Zhejiang Barty Medical Technology Revenue in Coronary Pathway Assistive Devices Business (2021-2026) & (US$ Million) Table 48. Zhejiang Barty Medical Technology Coronary Pathway Assistive Devices Product Portfolio Table 49. Zhejiang Barty Medical Technology Recent Developments Table 50. OrbusNeich Medical Company Company Information Table 51. OrbusNeich Medical Company Business Overview Table 52. OrbusNeich Medical Company Revenue in Coronary Pathway Assistive Devices Business (2021-2026) & (US$ Million) Table 53. OrbusNeich Medical Company Coronary Pathway Assistive Devices Product Portfolio Table 54. OrbusNeich Medical Company Recent Developments Table 55. MicroPort Scientific Corporation Company Information Table 56. MicroPort Scientific Corporation Business Overview Table 57. MicroPort Scientific Corporation Revenue in Coronary Pathway Assistive Devices Business (2021-2026) & (US$ Million) Table 58. MicroPort Scientific Corporation Coronary Pathway Assistive Devices Product Portfolio Table 59. MicroPort Scientific Corporation Recent Developments Table 60. Suzhou Innomed Medical Device Company Information Table 61. Suzhou Innomed Medical Device Business Overview Table 62. Suzhou Innomed Medical Device Revenue in Coronary Pathway Assistive Devices Business (2021-2026) & (US$ Million) Table 63. Suzhou Innomed Medical Device Coronary Pathway Assistive Devices Product Portfolio Table 64. Suzhou Innomed Medical Device Recent Developments Table 65. Shunmei Medical Company Information Table 66. Shunmei Medical Business Overview Table 67. Shunmei Medical Revenue in Coronary Pathway Assistive Devices Business (2021-2026) & (US$ Million) Table 68. Shunmei Medical Coronary Pathway Assistive Devices Product Portfolio Table 69. Shunmei Medical Recent Developments Table 70. Shenzhen MicroApproach Medical Technology Company Information Table 71. Shenzhen MicroApproach Medical Technology Business Overview Table 72. Shenzhen MicroApproach Medical Technology Revenue in Coronary Pathway Assistive Devices Business (2021-2026) & (US$ Million) Table 73. Shenzhen MicroApproach Medical Technology Coronary Pathway Assistive Devices Product Portfolio Table 74. Shenzhen MicroApproach Medical Technology Recent Developments Table 75. Shanghai INT Medical Instruments Company Information Table 76. Shanghai INT Medical Instruments Business Overview Table 77. Shanghai INT Medical Instruments Revenue in Coronary Pathway Assistive Devices Business (2021-2026) & (US$ Million) Table 78. Shanghai INT Medical Instruments Coronary Pathway Assistive Devices Product Portfolio Table 79. Shanghai INT Medical Instruments Recent Developments Table 80. Xiamen New Concept Medical Technology Company Information Table 81. Xiamen New Concept Medical Technology Business Overview Table 82. Xiamen New Concept Medical Technology Revenue in Coronary Pathway Assistive Devices Business (2021-2026) & (US$ Million) Table 83. Xiamen New Concept Medical Technology Coronary Pathway Assistive Devices Product Portfolio Table 84. Xiamen New Concept Medical Technology Recent Developments Table 85. Lepu Medical Technology Company Information Table 86. Lepu Medical Technology Business Overview Table 87. Lepu Medical Technology Revenue in Coronary Pathway Assistive Devices Business (2021-2026) & (US$ Million) Table 88. Lepu Medical Technology Coronary Pathway Assistive Devices Product Portfolio Table 89. Lepu Medical Technology Recent Developments Table 90. Jiangxi Hongda Medical Equipment Group Company Information Table 91. Jiangxi Hongda Medical Equipment Group Business Overview Table 92. Jiangxi Hongda Medical Equipment Group Revenue in Coronary Pathway Assistive Devices Business (2021-2026) & (US$ Million) Table 93. Jiangxi Hongda Medical Equipment Group Coronary Pathway Assistive Devices Product Portfolio Table 94. Jiangxi Hongda Medical Equipment Group Recent Developments Table 95. Jiangsu ChangMei Medtech Company Information Table 96. Jiangsu ChangMei Medtech Business Overview Table 97. Jiangsu ChangMei Medtech Revenue in Coronary Pathway Assistive Devices Business (2021-2026) & (US$ Million) Table 98. Jiangsu ChangMei Medtech Coronary Pathway Assistive Devices Product Portfolio Table 99. Jiangsu ChangMei Medtech Recent Developments Table 100. APT Medical Company Information Table 101. APT Medical Business Overview Table 102. APT Medical Revenue in Coronary Pathway Assistive Devices Business (2021-2026) & (US$ Million) Table 103. APT Medical Coronary Pathway Assistive Devices Product Portfolio Table 104. APT Medical Recent Developments Table 105. Changzhou JIUHONG Medical Instrument Company Information Table 106. Changzhou JIUHONG Medical Instrument Business Overview Table 107. Changzhou JIUHONG Medical Instrument Revenue in Coronary Pathway Assistive Devices Business (2021-2026) & (US$ Million) Table 108. Changzhou JIUHONG Medical Instrument Coronary Pathway Assistive Devices Product Portfolio Table 109. Changzhou JIUHONG Medical Instrument Recent Developments Table 110. BrosMed Medical Company Information Table 111. BrosMed Medical Business Overview Table 112. BrosMed Medical Revenue in Coronary Pathway Assistive Devices Business (2021-2026) & (US$ Million) Table 113. BrosMed Medical Coronary Pathway Assistive Devices Product Portfolio Table 114. BrosMed Medical Recent Developments Table 115. Beijing Demax Medical Technology Company Information Table 116. Beijing Demax Medical Technology Business Overview Table 117. Beijing Demax Medical Technology Revenue in Coronary Pathway Assistive Devices Business (2021-2026) & (US$ Million) Table 118. Beijing Demax Medical Technology Coronary Pathway Assistive Devices Product Portfolio Table 119. Beijing Demax Medical Technology Recent Developments Table 120. Terumo Corporation Company Information Table 121. Terumo Corporation Business Overview Table 122. Terumo Corporation Revenue in Coronary Pathway Assistive Devices Business (2021-2026) & (US$ Million) Table 123. Terumo Corporation Coronary Pathway Assistive Devices Product Portfolio Table 124. Terumo Corporation Recent Developments Table 125. Merit Medical Company Information Table 126. Merit Medical Business Overview Table 127. Merit Medical Revenue in Coronary Pathway Assistive Devices Business (2021-2026) & (US$ Million) Table 128. Merit Medical Coronary Pathway Assistive Devices Product Portfolio Table 129. Merit Medical Recent Developments Table 130. Medtronic Company Information Table 131. Medtronic Business Overview Table 132. Medtronic Revenue in Coronary Pathway Assistive Devices Business (2021-2026) & (US$ Million) Table 133. Medtronic Coronary Pathway Assistive Devices Product Portfolio Table 134. Medtronic Recent Developments Table 135. Curatia Medical Company Information Table 136. Curatia Medical Business Overview Table 137. Curatia Medical Revenue in Coronary Pathway Assistive Devices Business (2021-2026) & (US$ Million) Table 138. Curatia Medical Coronary Pathway Assistive Devices Product Portfolio Table 139. Curatia Medical Recent Developments Table 140. Cordis Company Information Table 141. Cordis Business Overview Table 142. Cordis Revenue in Coronary Pathway Assistive Devices Business (2021-2026) & (US$ Million) Table 143. Cordis Coronary Pathway Assistive Devices Product Portfolio Table 144. Cordis Recent Developments Table 145. Boston Scientific Company Information Table 146. Boston Scientific Business Overview Table 147. Boston Scientific Revenue in Coronary Pathway Assistive Devices Business (2021-2026) & (US$ Million) Table 148. Boston Scientific Coronary Pathway Assistive Devices Product Portfolio Table 149. Boston Scientific Recent Developments Table 150. ASAHI INTECC Company Information Table 151. ASAHI INTECC Business Overview Table 152. ASAHI INTECC Revenue in Coronary Pathway Assistive Devices Business (2021-2026) & (US$ Million) Table 153. ASAHI INTECC Coronary Pathway Assistive Devices Product Portfolio Table 154. ASAHI INTECC Recent Developments Table 155. Abbott Company Information Table 156. Abbott Business Overview Table 157. Abbott Revenue in Coronary Pathway Assistive Devices Business (2021-2026) & (US$ Million) Table 158. Abbott Coronary Pathway Assistive Devices Product Portfolio Table 159. Abbott Recent Developments Table 160. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Coronary Pathway Assistive Devices Product Image Figure 5. Global Coronary Pathway Assistive Devices Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Coronary Pathway Assistive Devices Market Share by Type: 2025 VS 2032 Figure 7. Angiographic Assistive Devices Product Figure 8. Therapeutic Assistive Devices Product Figure 9. Global Coronary Pathway Assistive Devices Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Coronary Pathway Assistive Devices Market Share by Application: 2025 VS 2032 Figure 11. Hospital Product Figure 12. Clinic Product Figure 13. Others Product Figure 14. Global Coronary Pathway Assistive Devices Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 15. Global Coronary Pathway Assistive Devices Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Coronary Pathway Assistive Devices Market Share by Region: 2025 VS 2032 Figure 17. Global Coronary Pathway Assistive Devices Market Share by Players in 2025 Figure 18. Global Coronary Pathway Assistive Devices Manufacturers Established Date Figure 19. Global Top 5 and 10 Coronary Pathway Assistive Devices Players Market Share by Revenue in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. North America Coronary Pathway Assistive Devices Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Coronary Pathway Assistive Devices Market Share by Country (2021-2032) Figure 23. United States Coronary Pathway Assistive Devices Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Canada Coronary Pathway Assistive Devices Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Mexico Coronary Pathway Assistive Devices Market Share by Country (2021-2032) Figure 26. Europe Coronary Pathway Assistive Devices Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Europe Coronary Pathway Assistive Devices Market Share by Country (2021-2032) Figure 28. Germany Coronary Pathway Assistive Devices Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. France Coronary Pathway Assistive Devices Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. U.K. Coronary Pathway Assistive Devices Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Italy Coronary Pathway Assistive Devices Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Spain Coronary Pathway Assistive Devices Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Russia Coronary Pathway Assistive Devices Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Netherlands Coronary Pathway Assistive Devices Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Nordic Countries Coronary Pathway Assistive Devices Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Coronary Pathway Assistive Devices Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Coronary Pathway Assistive Devices Market Share by Country (2021-2032) Figure 38. China Coronary Pathway Assistive Devices Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Japan Coronary Pathway Assistive Devices Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. South Korea Coronary Pathway Assistive Devices Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. India Coronary Pathway Assistive Devices Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. India Coronary Pathway Assistive Devices Market Share by Country (2021-2032) Figure 43. Australia Coronary Pathway Assistive Devices Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. China Taiwan Coronary Pathway Assistive Devices Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. Southeast Asia Coronary Pathway Assistive Devices Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. South America Coronary Pathway Assistive Devices Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. South America Coronary Pathway Assistive Devices Market Share by Country (2021-2032) Figure 48. Brazil Coronary Pathway Assistive Devices Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. Argentina Coronary Pathway Assistive Devices Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Chile Coronary Pathway Assistive Devices Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Colombia Coronary Pathway Assistive Devices Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Peru Coronary Pathway Assistive Devices Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Zhejiang Barty Medical Technology Revenue Growth Rate in Coronary Pathway Assistive Devices Business (2021-2026) Figure 54. OrbusNeich Medical Company Revenue Growth Rate in Coronary Pathway Assistive Devices Business (2021-2026) Figure 55. MicroPort Scientific Corporation Revenue Growth Rate in Coronary Pathway Assistive Devices Business (2021-2026) Figure 56. Suzhou Innomed Medical Device Revenue Growth Rate in Coronary Pathway Assistive Devices Business (2021-2026) Figure 57. Shunmei Medical Revenue Growth Rate in Coronary Pathway Assistive Devices Business (2021-2026) Figure 58. Shenzhen MicroApproach Medical Technology Revenue Growth Rate in Coronary Pathway Assistive Devices Business (2021-2026) Figure 59. Shanghai INT Medical Instruments Revenue Growth Rate in Coronary Pathway Assistive Devices Business (2021-2026) Figure 60. Xiamen New Concept Medical Technology Revenue Growth Rate in Coronary Pathway Assistive Devices Business (2021-2026) Figure 61. Lepu Medical Technology Revenue Growth Rate in Coronary Pathway Assistive Devices Business (2021-2026) Figure 62. Jiangxi Hongda Medical Equipment Group Revenue Growth Rate in Coronary Pathway Assistive Devices Business (2021-2026) Figure 63. Jiangsu ChangMei Medtech Revenue Growth Rate in Coronary Pathway Assistive Devices Business (2021-2026) Figure 64. APT Medical Revenue Growth Rate in Coronary Pathway Assistive Devices Business (2021-2026) Figure 65. Changzhou JIUHONG Medical Instrument Revenue Growth Rate in Coronary Pathway Assistive Devices Business (2021-2026) Figure 66. BrosMed Medical Revenue Growth Rate in Coronary Pathway Assistive Devices Business (2021-2026) Figure 67. Beijing Demax Medical Technology Revenue Growth Rate in Coronary Pathway Assistive Devices Business (2021-2026) Figure 68. Terumo Corporation Revenue Growth Rate in Coronary Pathway Assistive Devices Business (2021-2026) Figure 69. Merit Medical Revenue Growth Rate in Coronary Pathway Assistive Devices Business (2021-2026) Figure 70. Medtronic Revenue Growth Rate in Coronary Pathway Assistive Devices Business (2021-2026) Figure 71. Curatia Medical Revenue Growth Rate in Coronary Pathway Assistive Devices Business (2021-2026) Figure 72. Cordis Revenue Growth Rate in Coronary Pathway Assistive Devices Business (2021-2026) Figure 73. Boston Scientific Revenue Growth Rate in Coronary Pathway Assistive Devices Business (2021-2026) Figure 74. ASAHI INTECC Revenue Growth Rate in Coronary Pathway Assistive Devices Business (2021-2026) Figure 75. Abbott Revenue Growth Rate in Coronary Pathway Assistive Devices Business (2021-2026)

Scope & coverage.

Types
  • Angiographic Assistive Devices
  • Therapeutic Assistive Devices
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Zhejiang Barty Medical Technology
  • OrbusNeich Medical Company
  • MicroPort Scientific Corporation
  • Suzhou Innomed Medical Device
  • Shunmei Medical
  • Shenzhen MicroApproach Medical Technology
  • Shanghai INT Medical Instruments
  • Xiamen New Concept Medical Technology
  • Lepu Medical Technology
  • Jiangxi Hongda Medical Equipment Group
  • Jiangsu ChangMei Medtech
  • APT Medical
  • Changzhou JIUHONG Medical Instrument
  • BrosMed Medical
  • Beijing Demax Medical Technology
  • Terumo Corporation
  • Merit Medical
  • Medtronic
  • Curatia Medical
  • Cordis
  • Boston Scientific
  • ASAHI INTECC
  • Abbott

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Coronary Pathway Assistive Devices by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Angiographic Assistive Devices
  5. 2.2.3 Therapeutic Assistive Devices
  6. 2.3 Coronary Pathway Assistive Devices by Application
  7. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  8. 2.3.2 Hospital
  9. 2.3.3 Clinic
  10. 2.3.4 Others
  11. 2.4 Assumptions and Limitations
3 Coronary Pathway Assistive Devices Breakdown Data by Type
  1. 3.1 Global Coronary Pathway Assistive Devices Historic Market Size by Type (2021-2026)
  2. 3.2 Global Coronary Pathway Assistive Devices Forecasted Market Size by Type (2027-2032)
4 Coronary Pathway Assistive Devices Breakdown Data by Application
  1. 4.1 Global Coronary Pathway Assistive Devices Historic Market Size by Application (2021-2026)
  2. 4.2 Global Coronary Pathway Assistive Devices Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Coronary Pathway Assistive Devices Market Perspective (2021-2032)
  2. 5.2 Global Coronary Pathway Assistive Devices Growth Trends by Region
  3. 5.2.1 Global Coronary Pathway Assistive Devices Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Coronary Pathway Assistive Devices Historic Market Size by Region (2021-2026)
  5. 5.2.3 Coronary Pathway Assistive Devices Forecasted Market Size by Region (2027-2032)
  6. 5.3 Coronary Pathway Assistive Devices Market Dynamics
  7. 5.3.1 Coronary Pathway Assistive Devices Industry Trends
  8. 5.3.2 Coronary Pathway Assistive Devices Market Drivers
  9. 5.3.3 Coronary Pathway Assistive Devices Market Challenges
  10. 5.3.4 Coronary Pathway Assistive Devices Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Coronary Pathway Assistive Devices Players by Revenue
  2. 6.1.1 Global Top Coronary Pathway Assistive Devices Players by Revenue (2021-2026)
  3. 6.1.2 Global Coronary Pathway Assistive Devices Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Coronary Pathway Assistive Devices Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Coronary Pathway Assistive Devices Head Office and Area Served
  6. 6.4 Global Coronary Pathway Assistive Devices Players, Product Type & Application
  7. 6.5 Global Coronary Pathway Assistive Devices Manufacturers Established Date
  8. 6.6 Global Coronary Pathway Assistive Devices Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Coronary Pathway Assistive Devices Market Size (2021-2032)
  2. 7.2 North America Coronary Pathway Assistive Devices Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Coronary Pathway Assistive Devices Market Size by Country (2021-2026)
  4. 7.4 North America Coronary Pathway Assistive Devices Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Coronary Pathway Assistive Devices Market Size (2021-2032)
  2. 8.2 Europe Coronary Pathway Assistive Devices Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Coronary Pathway Assistive Devices Market Size by Country (2021-2026)
  4. 8.4 Europe Coronary Pathway Assistive Devices Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Coronary Pathway Assistive Devices Market Size (2021-2032)
  2. 9.2 Asia-Pacific Coronary Pathway Assistive Devices Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Coronary Pathway Assistive Devices Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Coronary Pathway Assistive Devices Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Coronary Pathway Assistive Devices Market Size (2021-2032)
  2. 10.2 South America Coronary Pathway Assistive Devices Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Coronary Pathway Assistive Devices Market Size by Country (2021-2026)
  4. 10.4 South America Coronary Pathway Assistive Devices Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Coronary Pathway Assistive Devices Market Size (2021-2032)
  2. 11.2 Middle East & Africa Coronary Pathway Assistive Devices Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Coronary Pathway Assistive Devices Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Coronary Pathway Assistive Devices Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Zhejiang Barty Medical Technology
  2. 12.1.1 Zhejiang Barty Medical Technology Company Information
  3. 12.1.2 Zhejiang Barty Medical Technology Business Overview
  4. 12.1.3 Zhejiang Barty Medical Technology Revenue in Coronary Pathway Assistive Devices Business (2021-2026)
  5. 12.1.4 Zhejiang Barty Medical Technology Coronary Pathway Assistive Devices Product Portfolio
  6. 12.1.5 Zhejiang Barty Medical Technology Recent Developments
  7. 12.2 OrbusNeich Medical Company
  8. 12.2.1 OrbusNeich Medical Company Company Information
  9. 12.2.2 OrbusNeich Medical Company Business Overview
  10. 12.2.3 OrbusNeich Medical Company Revenue in Coronary Pathway Assistive Devices Business (2021-2026)
  11. 12.2.4 OrbusNeich Medical Company Coronary Pathway Assistive Devices Product Portfolio
  12. 12.2.5 OrbusNeich Medical Company Recent Developments
  13. 12.3 MicroPort Scientific Corporation
  14. 12.3.1 MicroPort Scientific Corporation Company Information
  15. 12.3.2 MicroPort Scientific Corporation Business Overview
  16. 12.3.3 MicroPort Scientific Corporation Revenue in Coronary Pathway Assistive Devices Business (2021-2026)
  17. 12.3.4 MicroPort Scientific Corporation Coronary Pathway Assistive Devices Product Portfolio
  18. 12.3.5 MicroPort Scientific Corporation Recent Developments
  19. 12.4 Suzhou Innomed Medical Device
  20. 12.4.1 Suzhou Innomed Medical Device Company Information
  21. 12.4.2 Suzhou Innomed Medical Device Business Overview
  22. 12.4.3 Suzhou Innomed Medical Device Revenue in Coronary Pathway Assistive Devices Business (2021-2026)
  23. 12.4.4 Suzhou Innomed Medical Device Coronary Pathway Assistive Devices Product Portfolio
  24. 12.4.5 Suzhou Innomed Medical Device Recent Developments
  25. 12.5 Shunmei Medical
  26. 12.5.1 Shunmei Medical Company Information
  27. 12.5.2 Shunmei Medical Business Overview
  28. 12.5.3 Shunmei Medical Revenue in Coronary Pathway Assistive Devices Business (2021-2026)
  29. 12.5.4 Shunmei Medical Coronary Pathway Assistive Devices Product Portfolio
  30. 12.5.5 Shunmei Medical Recent Developments
  31. 12.6 Shenzhen MicroApproach Medical Technology
  32. 12.6.1 Shenzhen MicroApproach Medical Technology Company Information
  33. 12.6.2 Shenzhen MicroApproach Medical Technology Business Overview
  34. 12.6.3 Shenzhen MicroApproach Medical Technology Revenue in Coronary Pathway Assistive Devices Business (2021-2026)
  35. 12.6.4 Shenzhen MicroApproach Medical Technology Coronary Pathway Assistive Devices Product Portfolio
  36. 12.6.5 Shenzhen MicroApproach Medical Technology Recent Developments
  37. 12.7 Shanghai INT Medical Instruments
  38. 12.7.1 Shanghai INT Medical Instruments Company Information
  39. 12.7.2 Shanghai INT Medical Instruments Business Overview
  40. 12.7.3 Shanghai INT Medical Instruments Revenue in Coronary Pathway Assistive Devices Business (2021-2026)
  41. 12.7.4 Shanghai INT Medical Instruments Coronary Pathway Assistive Devices Product Portfolio
  42. 12.7.5 Shanghai INT Medical Instruments Recent Developments
  43. 12.8 Xiamen New Concept Medical Technology
  44. 12.8.1 Xiamen New Concept Medical Technology Company Information
  45. 12.8.2 Xiamen New Concept Medical Technology Business Overview
  46. 12.8.3 Xiamen New Concept Medical Technology Revenue in Coronary Pathway Assistive Devices Business (2021-2026)
  47. 12.8.4 Xiamen New Concept Medical Technology Coronary Pathway Assistive Devices Product Portfolio
  48. 12.8.5 Xiamen New Concept Medical Technology Recent Developments
  49. 12.9 Lepu Medical Technology
  50. 12.9.1 Lepu Medical Technology Company Information
  51. 12.9.2 Lepu Medical Technology Business Overview
  52. 12.9.3 Lepu Medical Technology Revenue in Coronary Pathway Assistive Devices Business (2021-2026)
  53. 12.9.4 Lepu Medical Technology Coronary Pathway Assistive Devices Product Portfolio
  54. 12.9.5 Lepu Medical Technology Recent Developments
  55. 12.10 Jiangxi Hongda Medical Equipment Group
  56. 12.10.1 Jiangxi Hongda Medical Equipment Group Company Information
  57. 12.10.2 Jiangxi Hongda Medical Equipment Group Business Overview
  58. 12.10.3 Jiangxi Hongda Medical Equipment Group Revenue in Coronary Pathway Assistive Devices Business (2021-2026)
  59. 12.10.4 Jiangxi Hongda Medical Equipment Group Coronary Pathway Assistive Devices Product Portfolio
  60. 12.10.5 Jiangxi Hongda Medical Equipment Group Recent Developments
  61. 12.11 Jiangsu ChangMei Medtech
  62. 12.11.1 Jiangsu ChangMei Medtech Company Information
  63. 12.11.2 Jiangsu ChangMei Medtech Business Overview
  64. 12.11.3 Jiangsu ChangMei Medtech Revenue in Coronary Pathway Assistive Devices Business (2021-2026)
  65. 12.11.4 Jiangsu ChangMei Medtech Coronary Pathway Assistive Devices Product Portfolio
  66. 12.11.5 Jiangsu ChangMei Medtech Recent Developments
  67. 12.12 APT Medical
  68. 12.12.1 APT Medical Company Information
  69. 12.12.2 APT Medical Business Overview
  70. 12.12.3 APT Medical Revenue in Coronary Pathway Assistive Devices Business (2021-2026)
  71. 12.12.4 APT Medical Coronary Pathway Assistive Devices Product Portfolio
  72. 12.12.5 APT Medical Recent Developments
  73. 12.13 Changzhou JIUHONG Medical Instrument
  74. 12.13.1 Changzhou JIUHONG Medical Instrument Company Information
  75. 12.13.2 Changzhou JIUHONG Medical Instrument Business Overview
  76. 12.13.3 Changzhou JIUHONG Medical Instrument Revenue in Coronary Pathway Assistive Devices Business (2021-2026)
  77. 12.13.4 Changzhou JIUHONG Medical Instrument Coronary Pathway Assistive Devices Product Portfolio
  78. 12.13.5 Changzhou JIUHONG Medical Instrument Recent Developments
  79. 12.14 BrosMed Medical
  80. 12.14.1 BrosMed Medical Company Information
  81. 12.14.2 BrosMed Medical Business Overview
  82. 12.14.3 BrosMed Medical Revenue in Coronary Pathway Assistive Devices Business (2021-2026)
  83. 12.14.4 BrosMed Medical Coronary Pathway Assistive Devices Product Portfolio
  84. 12.14.5 BrosMed Medical Recent Developments
  85. 12.15 Beijing Demax Medical Technology
  86. 12.15.1 Beijing Demax Medical Technology Company Information
  87. 12.15.2 Beijing Demax Medical Technology Business Overview
  88. 12.15.3 Beijing Demax Medical Technology Revenue in Coronary Pathway Assistive Devices Business (2021-2026)
  89. 12.15.4 Beijing Demax Medical Technology Coronary Pathway Assistive Devices Product Portfolio
  90. 12.15.5 Beijing Demax Medical Technology Recent Developments
  91. 12.16 Terumo Corporation
  92. 12.16.1 Terumo Corporation Company Information
  93. 12.16.2 Terumo Corporation Business Overview
  94. 12.16.3 Terumo Corporation Revenue in Coronary Pathway Assistive Devices Business (2021-2026)
  95. 12.16.4 Terumo Corporation Coronary Pathway Assistive Devices Product Portfolio
  96. 12.16.5 Terumo Corporation Recent Developments
  97. 12.17 Merit Medical
  98. 12.17.1 Merit Medical Company Information
  99. 12.17.2 Merit Medical Business Overview
  100. 12.17.3 Merit Medical Revenue in Coronary Pathway Assistive Devices Business (2021-2026)
  101. 12.17.4 Merit Medical Coronary Pathway Assistive Devices Product Portfolio
  102. 12.17.5 Merit Medical Recent Developments
  103. 12.18 Medtronic
  104. 12.18.1 Medtronic Company Information
  105. 12.18.2 Medtronic Business Overview
  106. 12.18.3 Medtronic Revenue in Coronary Pathway Assistive Devices Business (2021-2026)
  107. 12.18.4 Medtronic Coronary Pathway Assistive Devices Product Portfolio
  108. 12.18.5 Medtronic Recent Developments
  109. 12.19 Curatia Medical
  110. 12.19.1 Curatia Medical Company Information
  111. 12.19.2 Curatia Medical Business Overview
  112. 12.19.3 Curatia Medical Revenue in Coronary Pathway Assistive Devices Business (2021-2026)
  113. 12.19.4 Curatia Medical Coronary Pathway Assistive Devices Product Portfolio
  114. 12.19.5 Curatia Medical Recent Developments
  115. 12.20 Cordis
  116. 12.20.1 Cordis Company Information
  117. 12.20.2 Cordis Business Overview
  118. 12.20.3 Cordis Revenue in Coronary Pathway Assistive Devices Business (2021-2026)
  119. 12.20.4 Cordis Coronary Pathway Assistive Devices Product Portfolio
  120. 12.20.5 Cordis Recent Developments
  121. 12.21 Boston Scientific
  122. 12.21.1 Boston Scientific Company Information
  123. 12.21.2 Boston Scientific Business Overview
  124. 12.21.3 Boston Scientific Revenue in Coronary Pathway Assistive Devices Business (2021-2026)
  125. 12.21.4 Boston Scientific Coronary Pathway Assistive Devices Product Portfolio
  126. 12.21.5 Boston Scientific Recent Developments
  127. 12.22 ASAHI INTECC
  128. 12.22.1 ASAHI INTECC Company Information
  129. 12.22.2 ASAHI INTECC Business Overview
  130. 12.22.3 ASAHI INTECC Revenue in Coronary Pathway Assistive Devices Business (2021-2026)
  131. 12.22.4 ASAHI INTECC Coronary Pathway Assistive Devices Product Portfolio
  132. 12.22.5 ASAHI INTECC Recent Developments
  133. 12.23 Abbott
  134. 12.23.1 Abbott Company Information
  135. 12.23.2 Abbott Business Overview
  136. 12.23.3 Abbott Revenue in Coronary Pathway Assistive Devices Business (2021-2026)
  137. 12.23.4 Abbott Coronary Pathway Assistive Devices Product Portfolio
  138. 12.23.5 Abbott Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst